Tech & Gadgets Oxford Biomedica welcomes Colin Bond amidst financial adjustmentsBy Dave Antrobus18 November 2024 Oxford Biomedica, the cell and gene therapy pioneer, is undergoing significant board changes.Colin Bond, previously with Sandoz, joins the Oxford…
